Genetic polymorphic studies of wuchereria bancrofti antioxidant and vaccine candidate genes and their functional impact

Abstract

Lymphatic filariasis causes physical and social disability that newlineaffects over 100 million people in 83 countries in the developing world The newlinefeasibility to eliminate lymphatic filariasis is postulated to be mainly on newlinediagnosis to identify endemic areas followed by repeated cycles of mass drug newlineadministration MDA to reduce both infection prevalence and transmission newlinerates to levels below those required for sustained transmission Treatment for newlinelymphatic filariasis depends almost exclusively on drugs DEC ivermectin newlineand albendazole newline newline